Transparency International Germany vs. Ratiopharm
Case overview
Date filed |
20
April
2006
|
Current status |
Rejected
|
Issue |
Ratiopharm's unethical marketing in Germany, Belgium et al
|
Summary of the case |
Ratiopharm, a pharmaceuticals company and major producer of generic drugs, has allegedly engaged in unethical marketing practices, including bribing doctors and pharmacists in Belgium, Canada, Spain, Estonia and Germany.
|
Developments/Outcome |
In June 2006, the German NCP rejected the complaint citing the lack of transnational investment. Specifically, the NCP stated the complaint only dealt with alleged misbehaviour in Germany. In July 2006, Transparency International Germany resubmitted a revised and expanded complaint |
Relevant OECD Guidelines |
|
Case keywords |
Supply chain,
Anti-competitive practices,
Investment nexus,
Disclosure of information,
Bribery / Corruption,
Multiple NCPs
|
NCP Information
Complainant
Company Information
Timeline of developments
Some developments are only visible to logged in users.
Date |
Actor |
Action |
Description |
Document |
18
July
2006
|
Transparency International - Germany |
file |
TI submits revised and expanded complaint (see: Transparency International - Germany vs. Ratiopharm refile). |
|
20
April
2006
|
Transparency International - Germany |
file |
Complaint submitted to German NCP. |
|